Clinical impact of rare variants associated with inherited channelopathies: a 5-year update
Authors:
Open Access
- 21 September 2021
- journal article
- research article
- Published by Springer Nature in Human Genetics
- Vol. 141 (10) , 1579-1589
Abstract
A proper interpretation of the pathogenicity of rare variants is crucial before clinical translation. Ongoing addition of new data may modify previous variant classifications; however, how often a reanalysis is necessary remains undefined. We aimed to extensively reanalyze rare variants associated with inherited channelopathies originally classified 5 years ago and its clinical impact. In 2016, rare variants identified through genetic analysis were classified following the American College of Medical Genetics and Genomics’ recommendations. Five years later, we have reclassified the same variants following the same recommendations but including new available data. Potential clinical implications were discussed. Our cohort included 49 cases of inherited channelopathies diagnosed in 2016. Update show that 18.36% of the variants changed classification mainly due to improved global frequency data. Reclassifications mostly occurred in minority genes associated with channelopathies. Similar percentage of variants remain as deleterious nowadays, located in main known genes (SCN5A, KCNH2 and KCNQ1). In 2016, 69.38% of variants were classified as unknown significance, but now, 53.06% of variants are classified as such, remaining the most common group. No management was modified after translation of genetic data into clinics. After 5 years, nearly 20% of rare variants associated with inherited channelopathies were reclassified. This supports performing periodic reanalyses of no more than 5 years since last classification. Use of newly available data is necessary, especially concerning global frequencies and family segregation. Personalized clinical translation of rare variants can be crucial to management if a significant change in classification is identified.Keywords
All Related Versions
Funding Information
- 'la Caixa' Foundation (LCF/PR/GN16/50290001, LCF/PR/GN19/50320002)
- Instituto de Salud Carlos III (FIS, PI17/01690)
- Universitat de Girona
This publication has 44 references indexed in Scilit:
- Distinguishing pathogenic mutations from background genetic noise in cardiology: The use of large genome databases for genetic interpretationClinical Genetics, 2017
- Utility of Post-Mortem Genetic Testing in Cases of Sudden Arrhythmic Death SyndromeJACC, 2017
- Classification of Genes: Standardized Clinical Validity Assessment of Gene-Disease Associations Aids Diagnostic Exome Analysis and ReclassificationsHuman Mutation, 2017
- Analysis of protein-coding genetic variation in 60,706 humansNature, 2016
- Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research ConsortiumThe American Journal of Human Genetics, 2016
- CardioPulse Articles2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death summarized by co-chairs‘Ten Commandments' of 2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac deathAdolfo J. de Bold PhD OC FRSC: a pioneer in cardiovascular medicineNatriuretic peptides in 2015Teachable moment or missed opportunity?European Heart Journal, 2015
- Genetic purgatory and the cardiac channelopathies: Exposing the variants of uncertain/unknown significance issueHeart Rhythm, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)EP Europace, 2011
- Natural Selection on Genes that Underlie Human Disease SusceptibilityCurrent Biology, 2008